
KUALA LUMPUR (Nov 19): Sunway Healthcare Holdings Bhd (KL:SUNMED) said its net profit for the third quarter jumped over 59% year-on-year, as the group saw rising demand and revenue from its operations nationwide.
The private hospital group recorded a net profit of RM95.17 million for the three months ended Sept 30, 2026 (3QFY2026), compared with RM59.69 million in the same period last year, supported by stronger operating earnings and lower net finance costs despite its expansion.
Revenue for the quarter rose 24% to RM737.44 million from RM593.13 million, driven by sustained patient demand and higher hospital utilisation across the group's hospitals, as well as increased contributions from Sunway Medical Centre (SMC) Ipoh, Damansara, Velocity and Penang.
No dividend was declared for the quarter.
Sunway Healthcare said its bed occupancy rate improved to 77% from about 71% in 3QFY2025, reflecting stronger utilisation of the group’s operating capacity.
Inpatient admissions increased 21% year-on-year to 36,541, while average revenue per inpatient admission rose 5% to RM12,339 during the quarter.
For the nine-month period of FY2026, Sunway Healthcare’s net profit grew 48% to RM206.66 million from RM139.83 million in the corresponding period last year, while revenue increased 26% to RM2.00 billion from RM1.59 billion.
As at Sept 30, the group had 1,994 licensed beds and a further 277 completed beds available for licensing, bringing its total capacity to 2,271 beds.
Sunway Healthcare will continue to progressively license and operationalise its remaining capacity, particularly at Sunway Medical Centre (SMC) Sunway City’s Tower F, SMC Damansara and SMC Ipoh, its president Datuk Lau Beng Long said in a statement.
“In parallel, brownfield development programmes at SMC Damansara and SMC Penang, together with ongoing greenfield and Ambulatory Care Centre initiatives, are expected to provide additional capacity to support the group’s medium- and longer-term growth,” he said.
On MediAsas and the progressive implementation of the diagnosis-related group (DRG) framework, Lau said the group would continue to engage constructively with insurers, takaful operators and relevant stakeholders.
The group expects to protect margins through disciplined pricing and discount governance, procurement initiatives, clinical cost management and continued improvements in operating productivity.
Medical tourism also remains an important growth opportunity, supported by Malaysia’s established position as a regional healthcare destination.
“The group will continue to broaden its international patient source markets, deepen referral and insurer partnerships, and strengthen higher-value specialist offerings, while remaining mindful of geopolitical developments and regional travel uncertainties.
“With its established hospital network, growing specialist capabilities and expanding capacity, the group will remain focused on converting patient-volume growth and progressive capacity activation into sustainable earnings, while maintaining clinical excellence, operational resilience and financial discipline,” Lau added.
At Thursday’s noon break, Sunway Healthcare shares rose one sen, or 0.48%, to RM2.09, giving the group a market capitalisation of RM24.05 billion.